Noriaki Yamamoto - Santen Pharmaceutical Insider

Santen Pharmaceutical Co Ltd -- USA Stock  

USD 16.58  0.21  1.25%

CIO, Head of Information Systems Division and Corporate Officer

We currently do not have informatin regarding Noriaki Yamamoto. This executive tanure with Santen Pharmaceutical Co Ltd is not currenlty determined.
81 6 6321 7000

Management Efficiency

The company has return on total asset (ROA) of 6.34 % which means that it generated profit of $6.34 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 11.43 % meaning that it generated $11.43 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

Santen Pharmaceutical Co., Ltd., together with its subsidiaries, researches and develops, produces, and markets prescription ophthalmic pharmaceutical products for the protection and enhancement of eyesight and health primarily in Japan. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical is traded on OTC Market in USA.Santen Pharmaceutical Co Ltd (SNPHY) is traded on OTC Market in USA. It is located in Grand Front Osaka Tower A and employs 3,667 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Santen Pharmaceutical Co Ltd to your portfolio

Top Management

Santen Pharmaceutical Co Leadership Team
Satoshi Suzuki, Director
Kanoko Ohishi, Director
Noriaki Yamamoto, Executive
Akira Kurokawa, CEO
Hidetaka Mizutani, Executive
Kenji Morishima, Director
Sadatoshi Furukado, Director
Masamichi Sato, Executive
Kazuo Koshiji, CFO
Akihiro Tsujimura, Director
Takeshi Ito, Director
Yutaro Shintaku, Director
Akihiro Okumura, Director
Yutaro Shinta, Director
Jyrki Liljeroos, President
Shiro Hatagami, Executive
Keizo Nakada, Director
Akio Kimura, Director
Naveed Shams, CEO
Atsutoshi Ohta, Director
Hiroyuki Yamazaki, Director
Takahiro Morita, Director
Ye Liu, Executive
Takayuki Katayama, Director
Shigeo Taniuchi, President

Stock Performance

Santen Pharmaceutical Performance Indicators